Keyphrases
Patients with Prostate Cancer
100%
Endocrine Therapy
100%
Phase II Study
25%
Prostate Cancer
25%
Newly Diagnosed
25%
Overall Survival
25%
Androgen Deprivation Therapy
25%
Per Se
12%
Prostate Cancer Risk
12%
Metastatic Castration-resistant Prostate Cancer (mCRPC)
12%
Patient Management
12%
Adjuvant Endocrine Therapy
12%
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
12%
Advanced Prostate Cancer
12%
Randomized Clinical Trial
12%
Randomized Trial
12%
Number of Trials
12%
Locally Advanced
12%
Radiotherapy
12%
Placebo
12%
Clinical Setting
12%
Nonmetastatic Prostate Cancer
12%
Radical Prostatectomy
12%
Tumor Burden
12%
Overall Mortality
12%
Effects on Survival
12%
Therapeutic Modalities
12%
Overall Survival Benefit
12%
Dogma
12%
Pharmacology, Toxicology and Pharmaceutical Science
Endocrine Therapy
100%
Prostate Cancer
100%
Diseases
30%
Overall Survival
30%
Androgen
20%
Cancer Specific Survival
20%
Castration Resistant Prostate Cancer
10%
Placebo
10%
Neoplasm
10%
Randomized Clinical Trial
10%
Hormone
10%